Reducing the incidence of TRALI in the UK: The results of screening for donor leucocyte antibodies and the development of national guidelines

Vox Sanguinis

Volumn 103, Issue 1, 2012, Pages 10-17

  Lucas, G ^a   Win, N ^a   Calvert, A ^a   Green, A ^a   Griffin, E ^a   Bendukidze, N ^a   Hopkins, M ^a   Browne, T ^a   Poles, A ^a   Chapman, C ^a   Massey, E ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood donors; Leucocyte antibodies; TRALI; UK guidelines

Indexed keywords

GRANULOCYTE ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIBODY;

ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; DONOR; DONOR LYMPHOCYTE INFUSION; FEMALE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; LEUKAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED KINGDOM;

ACUTE LUNG INJURY; ANTIBODIES; BLOOD COMPONENT REMOVAL; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; GREAT BRITAIN; HIGH-THROUGHPUT SCREENING ASSAYS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HUMANS; INCIDENCE; ISOANTIBODIES; LEUKOCYTES;

EID: 84862311640     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2011.01570.x     Document Type: Article

References (35)

1. Popovsky MA, Moore SB: Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25:573-577.
2. Popovsky MA: The Emily Cooley Lecture 2009. To breathe or not to breathe - that is the question. Transfusion 2010; 50:2057-2062.
3. Bux J: Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011; 100:122-128.
4. Wallis JP, Haynes S, Stark G, et al.: Transfusion related alloimmune neutropenia: an undescribed complication of blood transfusion. Lancet 2002; 360:1073-1074.
5. Toy P, Hollis-Perry K, Jun J, et al.: Transfusion complications: recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004; 44:1683-1688.
6. Win N, Ranasinghe E, Lucas G: Transfusion related acute lung injury: a 5-year lookback study. Transfus Med 2002; 12:387-389.
7. Silliman CC, Ambruso DR, Boshkov LK: Transfusion-related acute lung injury. Blood 2005; 105:2266-2273.
8. Win N, Massey E, Lucas G, et al.: Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome. Hematology 2007; 12:461-9.
9. Chapman CE, Stainsby D, Jones H, et al.: Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49:440-452.
10. Win N, Chapman CE, Bowles KM, et al.: How much residual plasma may cause TRALI? Transf Med 2008; 18:276-280.
11. Reil A, Keller-Stanislawski B, Gunay S, et al.: Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008; 95:313-317.
12. Kleinman S, Caulfield T, Chan P, et al.: Towards an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44:1774-1789.
13. Bux J: Transfusion-related acute lung injury: a serious adverse event of blood transfusion. Vox Sang 2005; 89:1-10.
14. Eder AF, Herron R, Strupp A, et al.: Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007; 47:599-607.
15. Wendel S, Biagini S, Trigo F, et al.: Measures to prevent TRALI. Vox Sang 2007; 92:258-277.
16. Knowles S (ed.), Cohen H, et al.: The 2010 Annual SHOT report (2011).
17. Bierling P, Bux J, Curtis B, et al.: Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang 2009; 96:266-269.
18. Lucas G, Rogers S, de Haas M, et al.: Report on the fourth International Granulocyte Immunology Workshop: progress toward quality assessment. Transfusion 2002; 42:462-468.
19. Froment P, Prie N, Simon P, et al.: Granulocyte antibody screening: evaluation of a bead-based assay in comparison with classical methods. Transfusion 2010; 50:2643-2648.
20. Verheugt FW, von dem Borne AE, Decary F, et al.: The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol 1977; 369:533-544.
21. Decary F, Vermeulen A, Engelfriet CP: A look at HLA antisera in the indirect immunofluorescence technique (IIFT); in Kissmeyer-Nielsen F (ed.): Histocompatibility Testing. Copenhagen, Munksgaard, 1975: 380-390.
22. Lucas GF: Prospective evaluation of the chemiluminescence test for the detection of granulocyte antibodies: Comparison with the granulocyte immunofluorescence test. Vox Sang 1994; 66:141-147.
23. Fadeyi E, Adams S, Peterson B, et al.: Analysis of a high throughput HLA antibody screening assay for use with platelet donors. Transfusion 2008; 48:1174-1179.
24. MacLennan S, Lucas G, Brown C, et al.: Prevalence of HLA and HNA antibodies in donors: correlation with pregnancy and transfusion history. Vox Sang 2004; 87(S3), 4 (abstract).
25. Powers A, Stowell CP, Dzik WH, et al.: Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy. Transfusion 2008; 48:2549-2555.
26. Triulzi DJ, Kleinman S, Kakaiya RM, et al.: The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49:1825-1835.
27. Middelburg RA, Porcelijn L, Lardy N, et al.: Prevalence of leucocyte antibodies in the Dutch donor population. Vox Sang 2011; 100:327-335.
28. Gottschall JL, Triulzi DJ, Curtis B, et al.: The frequency and specificity of human neutrophil antigen antibodies in a blood donor population. Transfusion 2011; 51:820-827.
29. Kopko PM, Marshall CS, MacKenzie MR, et al.: Transfusion-related acute lung injury report of a clinical look-back investigation. JAMA 2002; 287:1968-1971.
30. Davoren A, Curtis BR, Shulman IA, et al.: TRALI due to granulocyte-agglutinating human neutrophil antigen-3a(5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43:641-645.
31. Lucas G, Rogers S, Evans R, et al.: Transfusion related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a. Vox Sang 2000; 79:112-115.
32. Bayat B, Tjahjono Y, Werth S, et al.: Implication of transfected cell lines for the detection of alloantibodies against human neutrophil antigen-3. Transfusion 2011; PMID 2188 3263 [Epub ahead of print].
33. Wozniak MJ, Bowring C, Lucas G, et al.: Detection of HNA-3a and -3b antibodies using transfected cell lines and recombinant proteins. Transfusion (accepted for publication).
34. Reil A, Wesche J, Greinacher A, et al.: Geno- and phenotyping and immunogenicity of HNA-3. Transfusion 2011; 51:18-24.
35. Lefaucheur C, Loupy A, Hill GS, et al.: Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010; 21:1398-1406.